{"id":"NCT01069900","sponsor":"Bayer","briefTitle":"Moxifloxacin in Pediatric Subjects With Complicated Intra-abdominal Infection","officialTitle":"A Randomized, Double-blind, Multicenter Trial to Evaluate the Safety and Efficacy of Sequential (Intravenous, Oral) Moxifloxacin Versus Comparator in Pediatric Subjects With Complicated Intra-abdominal Infection","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-07-21","primaryCompletion":"2015-01-21","completion":"2015-01-21","firstPosted":"2010-02-17","resultsPosted":"2015-12-08","lastUpdate":"2018-03-20"},"enrollment":458,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Intraabdominal Infections"],"interventions":[{"type":"DRUG","name":"Moxifloxacin (Avelox, BAY12-8039)","otherNames":[]},{"type":"DRUG","name":"Ertapenem","otherNames":[]},{"type":"DRUG","name":"Amoxicillin/Clavulanate","otherNames":[]},{"type":"DRUG","name":"Moxifloxacin placebo","otherNames":[]},{"type":"DRUG","name":"Ertapenem placebo","otherNames":[]},{"type":"DRUG","name":"Amoxicillin/Clavulanate placebo","otherNames":[]}],"arms":[{"label":"Moxifloxacin (Avelox, BAY12-8039)","type":"EXPERIMENTAL"},{"label":"Comparator Ertapenem","type":"ACTIVE_COMPARATOR"}],"summary":"The primary focus of the study is the evaluation of the safety of treatment with moxifloxacin in a pediatric population 3 months to \\<18 years old. Approximately 450 pediatric subjects with a complicated intra-abdominal infection will be enrolled in the study and treated with either moxifloxacin intravenously and orally if switched to oral therapy or ertapenem (intravenously) and, if switched to oral therapy, amoxicillin/clavulanate.","primaryOutcome":{"measure":"Number of Subjects With Adverse Events","timeFrame":"All AEs and SAE were recorded from treatment start to test of cure visit; musculoskeletal AEs were recorded up to 1 year post-end of treatment (EOT) visit; subjects with musculoskeletal AEs 1 year after EOT were followed up to 5 years or until resolution.","effectByArm":[{"arm":"Moxifloxacin (Avelox, BAY12-8039)","deltaMin":175,"sd":null},{"arm":"Comparator Ertapenem","deltaMin":82,"sd":null}],"pValues":[]},"eligibility":{"minAge":"3 Months","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":11},"locations":{"siteCount":39,"countries":["United States","Argentina","Bulgaria","Canada","Chile","Czechia","Germany","Greece","Hungary","Latvia","Lithuania","Mexico","Peru","Romania","Russia","Ukraine"]},"refs":{"pmids":["29356761"],"seeAlso":["http://www.clinicaltrialsregister.eu/"]},"adverseEventsSummary":{"seriousAny":{"events":20,"n":301},"commonTop":["Incision site pain","Vomiting","Electrocardiogram QT prolonged","Procedural pain","Wound infection"]}}